Filing Details

Accession Number:
0001209191-11-024395
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-26 15:40:40
Reporting Period:
2011-04-25
Filing Date:
2011-04-26
Accepted Time:
2011-04-26 15:40:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349077 Lisa Kelly C/O Vertex Pharmaceuticals Incorporated
130 Waverly St
Cambridge MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-25 953 $28.84 43,195 No 4 M Direct
Common Stock Disposition 2011-04-25 953 $50.00 42,242 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2011-04-25 953 $0.00 953 $28.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,204 2007-10-12 2017-07-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,182 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
  2. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/12/2007.